1. Home
  2. SLN
  3. SLN News

Latest Silence Therapeutics Plc American Depository Share (SLN) News on February 23, 2025

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025
SLN

Business Wire

10 days ago

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

SLN

MT Newswires

11 days ago

Silence Therapeutics Shares Fall After Goldman Sachs Initiates Coverage at Sell

Institutional owners may take dramatic actions as Silence Therapeutics plc's (NASDAQ:SLN) recent 14% drop adds to one-year losses
SLN

Simply Wall St.

a month ago

Institutional owners may take dramatic actions as Silence Therapeutics plc's (NASDAQ:SLN) recent 14% drop adds to one-year losses

Silence Therapeutics plc (SLN): Among the Oversold Global Stocks to Buy Right Now
SLN

Insider Monkey

2 months ago

Silence Therapeutics plc (SLN): Among the Oversold Global Stocks to Buy Right Now

Insider Traders Lose UK£124k As Silence Therapeutics Drops
SLN

Simply Wall St.

2 months ago

Insider Traders Lose UK£124k As Silence Therapeutics Drops

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
SLN

Business Wire

2 months ago

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
SLN

Business Wire

3 months ago

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
SLN

Zacks

3 months ago

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
SLN

Benzinga

3 months ago

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
SLN

Business Wire

3 months ago

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations
SLN

Simply Wall St.

3 months ago

Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
SLN

Business Wire

3 months ago

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference
SLN

Business Wire

3 months ago

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Is Silence Therapeutics plc (SLN) a Promising Gene Editing Stock?
SLN

Insider Monkey

4 months ago

Is Silence Therapeutics plc (SLN) a Promising Gene Editing Stock?

We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely
SLN

Simply Wall St.

4 months ago

We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely

SLN

MT Newswires

6 months ago

Jefferies Initiates Silence Therapeutics at Buy With $40 Price Target

Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
SLN

Business Wire

6 months ago

Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences

Silence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
SLN

Simply Wall St.

6 months ago

Silence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Silence Therapeutics Second Quarter 2024 Earnings: Misses Expectations
SLN

Simply Wall St.

6 months ago

Silence Therapeutics Second Quarter 2024 Earnings: Misses Expectations

SLN

MT Newswires

6 months ago

Silence Therapeutics' Q2 Loss Widens as Revenue Falls

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
SLN

Business Wire

6 months ago

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Institutional investors are Silence Therapeutics plc's (NASDAQ:SLN) biggest bettors and were rewarded after last week's US$76m market cap gain
SLN

Simply Wall St.

7 months ago

Institutional investors are Silence Therapeutics plc's (NASDAQ:SLN) biggest bettors and were rewarded after last week's US$76m market cap gain

Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?
SLN

Zacks

7 months ago

Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?

SLN

MT Newswires

8 months ago

Chardan Raises Price Target on Silence Therapeutics to $55 From $42, Maintains Buy Rating

SLN

MT Newswires

8 months ago

Morgan Stanley Raises Price Target on Silence Therapeutics to $49 From $45, Keeps Overweight Rating

SLN

MT Newswires

8 months ago

Silence Therapeutics Says Divesiran Shows Sustained Hematocrit Reduction in Blood Cancer Study

Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients
SLN

Business Wire

8 months ago

Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients

SLN

Business Wire

8 months ago

Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration

Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
SLN

Business Wire

8 months ago

Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)

One Silence Therapeutics Insider Raised Their Stake In The Previous Year
SLN

Simply Wall St.

8 months ago

One Silence Therapeutics Insider Raised Their Stake In The Previous Year

Silence Therapeutics to Present at Jefferies Global Healthcare Conference
SLN

Business Wire

9 months ago

Silence Therapeutics to Present at Jefferies Global Healthcare Conference

Silence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth Plans
SLN

Simply Wall St.

9 months ago

Silence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth Plans

Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
SLN

Business Wire

9 months ago

Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
SLN

Business Wire

10 months ago

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
SLN

Business Wire

10 months ago

Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
SLN

Zacks

10 months ago

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
SLN

Business Wire

10 months ago

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)

Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results
SLN

Simply Wall St.

a year ago

Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results

Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
SLN

Insider Monkey

a year ago

Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript

Silence Therapeutics Full Year 2023 Earnings: Misses Expectations
SLN

Simply Wall St.

a year ago

Silence Therapeutics Full Year 2023 Earnings: Misses Expectations

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
SLN

Business Wire

a year ago

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
SLN

Business Wire

a year ago

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)

MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
SLN

Zacks

a year ago

MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?

Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock?
SLN

Zacks

a year ago

Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock?

Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
SLN

Business Wire

a year ago

Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024

Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
SLN

Business Wire

a year ago

Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?
SLN

Zacks

a year ago

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?

Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher
SLN

Simply Wall St.

a year ago

Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
SLN

Business Wire

a year ago

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement

Shenandoah Telecommunications Company to Hold its Fourth Quarter and Full Year 2023 Earnings Call at 8:30 a.m. on Wednesday, February 21, 2024
SLN

GlobeNewswire

a year ago

Shenandoah Telecommunications Company to Hold its Fourth Quarter and Full Year 2023 Earnings Call at 8:30 a.m. on Wednesday, February 21, 2024

Strength Seen in Silence Therapeutics PLC Sponsored ADR (SLN): Can Its 15.4% Jump Turn into More Strength?
SLN

Zacks

a year ago

Strength Seen in Silence Therapeutics PLC Sponsored ADR (SLN): Can Its 15.4% Jump Turn into More Strength?

Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
SLN

Business Wire

a year ago

Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Hamilton Lane (HLNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
SLN

Zacks

a year ago

Hamilton Lane (HLNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

AMERANT BANK PROVIDES FINANCING TO FRESCO RETAIL GROUP, LLC FOR THE ACQUISITION OF FRESCO Y MÁS OPERATIONS AND LOCATIONS
SLN

GlobeNewswire

a year ago

AMERANT BANK PROVIDES FINANCING TO FRESCO RETAIL GROUP, LLC FOR THE ACQUISITION OF FRESCO Y MÁS OPERATIONS AND LOCATIONS

Allegiant Reports December 2023 Traffic
SLN

PR Newswire

a year ago

Allegiant Reports December 2023 Traffic

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Dips More Than Broader Market: What You Should Know
SLN

Zacks

a year ago

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Dips More Than Broader Market: What You Should Know

Alpha and Omega Semiconductor Announces Closing of DOJ Investigation
SLN

Business Wire

a year ago

Alpha and Omega Semiconductor Announces Closing of DOJ Investigation

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Stock Sinks As Market Gains: What You Should Know
SLN

Zacks

a year ago

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Stock Sinks As Market Gains: What You Should Know

Best Growth Stocks to Buy for January 24th
SLN

Zacks

a year ago

Best Growth Stocks to Buy for January 24th

Financial Statement Series: ChargePoint Stock Analysis
SLN

Motley Fool

a year ago

Financial Statement Series: ChargePoint Stock Analysis

Target Hospitality Announces Senior Level Promotions
SLN

PR Newswire

a year ago

Target Hospitality Announces Senior Level Promotions

Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m
SLN

Simply Wall St.

a year ago

Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m

First Merchants Corporation Announces Cash Dividend on Its Preferred Stock
SLN

GlobeNewswire

a year ago

First Merchants Corporation Announces Cash Dividend on Its Preferred Stock

SunCoke Energy, Inc. Announces Fourth Quarter 2023 Earnings Date
SLN

Business Wire

a year ago

SunCoke Energy, Inc. Announces Fourth Quarter 2023 Earnings Date

10 Small-Cap Energy Stocks with Strong Returns
SLN

Insider Monkey

a year ago

10 Small-Cap Energy Stocks with Strong Returns

Estimating The Fair Value Of WalkMe Ltd. (NASDAQ:WKME)
SLN

Simply Wall St.

a year ago

Estimating The Fair Value Of WalkMe Ltd. (NASDAQ:WKME)

AMC stock closes at a record low
SLN

Yahoo Finance

a year ago

AMC stock closes at a record low

World Acceptance Corporation Announces Third Quarter 2024 Conference Call on the Internet
SLN

Business Wire

a year ago

World Acceptance Corporation Announces Third Quarter 2024 Conference Call on the Internet

The 7 Best Meme Stocks to Buy in January 2024
SLN

InvestorPlace

a year ago

The 7 Best Meme Stocks to Buy in January 2024

Volaris First Quarter and Full Year 2024 Guidance
SLN

GlobeNewswire

a year ago

Volaris First Quarter and Full Year 2024 Guidance

SLN

Associated Press Finance

a year ago

TechTarget, Chesapeake Energy rise; Hertz Global, KB Home fall, Thursday, 1/11/2024

All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy
SLN

Zacks

a year ago

All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy

Aspen Aerogels, Inc. Provides Business Update
SLN

PR Newswire

a year ago

Aspen Aerogels, Inc. Provides Business Update

SLN

Reuters

a year ago

TechTarget to combine with UK-based Informa's digital businesses

TechTarget to Expand Scale and Leadership Position in B2B Data and Market Access through Strategic Combination with Informa Tech’s Digital Businesses
SLN

Business Wire

a year ago

TechTarget to Expand Scale and Leadership Position in B2B Data and Market Access through Strategic Combination with Informa Tech’s Digital Businesses

Virgin Galactic Stock Rises After Upgrade. Its Spacecraft Pivot Is Applauded.
SLN

Barrons.com

a year ago

Virgin Galactic Stock Rises After Upgrade. Its Spacecraft Pivot Is Applauded.

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
SLN

GlobeNewswire

a year ago

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum
SLN

Business Wire

a year ago

U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum

Silence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's Why
SLN

Zacks

a year ago

Silence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's Why

3 High-Octane Growth Stocks Ready to Hit New 52-Week Highs
SLN

InvestorPlace

a year ago

3 High-Octane Growth Stocks Ready to Hit New 52-Week Highs

American Woodmark (AMWD) Stock Moves -0.26%: What You Should Know
SLN

Zacks

a year ago

American Woodmark (AMWD) Stock Moves -0.26%: What You Should Know

1 Phenomenal Growth Stock Down 61% to Buy Hand Over Fist in 2024
SLN

Motley Fool

a year ago

1 Phenomenal Growth Stock Down 61% to Buy Hand Over Fist in 2024

Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
SLN

Zacks

a year ago

Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More

AvidXchange Holdings, Inc. (AVDX) is a Great Momentum Stock: Should You Buy?
SLN

Zacks

a year ago

AvidXchange Holdings, Inc. (AVDX) is a Great Momentum Stock: Should You Buy?

This Silence Therapeutics Insider Increased Their Holding In The Last Year
SLN

Simply Wall St.

a year ago

This Silence Therapeutics Insider Increased Their Holding In The Last Year

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024
SLN

Zacks

a year ago

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

New Strong Sell Stocks for December 20th
SLN

Zacks

a year ago

New Strong Sell Stocks for December 20th

Companies Like Cassava Sciences (NASDAQ:SAVA) Are In A Position To Invest In Growth
SLN

Simply Wall St.

a year ago

Companies Like Cassava Sciences (NASDAQ:SAVA) Are In A Position To Invest In Growth

Blueprint to Profit: 3 Top Construction Stocks to Invest In Now
SLN

InvestorPlace

a year ago

Blueprint to Profit: 3 Top Construction Stocks to Invest In Now

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year
SLN

Zacks

a year ago

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

Solar stocks poised for comeback in 2024
SLN

Yahoo Finance

a year ago

Solar stocks poised for comeback in 2024

Caleres Awarded on Newsweek’s America’s Most Responsible Companies 2024 List
SLN

Business Wire

a year ago

Caleres Awarded on Newsweek’s America’s Most Responsible Companies 2024 List

Does Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?
SLN

Zacks

a year ago

Does Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?

SLN

PR Newswire

a year ago

Calumet to Attend Wells Fargo Conference

SLN

PR Newswire

a year ago

Operational Update: Calumet Announces Montana Renewables Returns to Full Operations

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
SLN

Business Wire

a year ago

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Hesai Responds to False Allegations Raised by Members of Congress
SLN

GlobeNewswire

a year ago

Hesai Responds to False Allegations Raised by Members of Congress

Company News for Nov 29, 2023
SLN

Zacks

a year ago

Company News for Nov 29, 2023

Altus Power Kicks Off December Investor Engagement
SLN

Business Wire

a year ago

Altus Power Kicks Off December Investor Engagement

SLN

PR Newswire

a year ago

Calumet to Attend Bank of America Leveraged Finance Conference

Share on Social Networks: